Dapsone-induced sulfone syndrome

Annals of Pharmacotherapy

Volumn 37, Issue 7-8, 2003, Pages 1044-1046

  Lee, Kimberly B ^a,b   Nashed, Trisha B ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dapsone; Hepatitis; Methemoglobinemia; Sulfone syndrome

Indexed keywords

DAPSONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EXFOLIATIVE DERMATITIS; FEVER; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; MALE; METHEMOGLOBINEMIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SULFONE SYNDROME;

EID: 0037765132     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C432     Document Type: Article

References (12)

1. Tomecki KJ, Catalano CJ. Dapsone hypersensitivity: the sulfone syndrome revisited. Arch Dermatol 1981;117:38-9.
2. Mohle-Boetani J, Akula SK, Holodniy M, Katzenstein D, Garcia G. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia. West J Med 1992;156:303-6.
3. Johnson DA, Cattau EL, Kuritsky JN, Zimmerman H. Liver involvement in sulfone syndrome. Arch Intern Med 1986;146:875-7.
4. Chalasani P, Baffoe-Bonnie H, Jurado RL. Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient. South Med J 1994;87:1145-6.
5. Millikan LE, Harrell ER. Drug reactions to sulfones. Arch Dermatol 1970;102:220-4.
6. Kromann NP, Vilhelmsen R, Stahl D. The dapsone syndrome. Arch Dermatol 1982;118:531-2.
7. Lowe J, Smith M. The chemotherapy of leprosy in Nigeria, with an appendix of glandular fever and exfoliative dermatitis precipitated by sulfones. Int J Leprosy 1949;17:181-95.
8. Rege VL, Shukla P, Mascarenhas MF. Dapsone syndrome in Goa. Indian J Leprosy 1994;66:59-64.
9. Thong BY, Leong KP, Chng HH. Hypersensitivity syndrome associated with dapsone/pyrimethamine (Maloprim) antimalaria chemoprophylaxis. Ann Allergy Asthma Immunol 2002;88:527-9.
10. Prussick R, Shear NH. Dapsone hypersensitivity syndrome. J Am Acad Dermatol 1996;35:346-9.
11. Frey HM, Gerson AA, Borkowsky W, Bullock WE. Fatal reaction to dapsone during treatment of leprosy. Ann Intern Med 1981;84:777-9.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.